(Q39988627)

reason for preferred rank

16 September 2017

title

Clofibrate-induced low density lipoprotein elevation therapeutic implications and treatment by colestipol resin (English)

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

23 December 2022

Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A178325

Cardiology and cardiovascular medicine

23 December 2022

main subject

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

23 December 2022

author name string

H. G. Rose

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A178325

23 December 2022

G. K. Haft

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A178325

23 December 2022

J. Juliano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A178325

23 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=178325

23 December 2022

publication date

1 May 1976

1 reference

full work available at URL

16 September 2017

https://api.elsevier.com/content/article/PII:0021915076900034?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

https://api.elsevier.com/content/article/PII:0021915076900034?httpAccept=text/plain

23 December 2022

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

23 December 2022

1 reference

16 September 2017

volume

23

1 reference

16 September 2017

issue

3

1 reference

16 September 2017

page(s)

413-427

1 reference

A SYSTEM FOR PHENOTYPING HYPERLIPOPROTEINEMIA.

16 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

THE EFFECTS OF CHLOROPHENOXYISOBUTYRATE WITH AND WITHOUT ANDROSTERONE ON THE SERUM LIPIDS, FAT TOLERANCE, AND URIC ACID

23 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Long-term effects of clofibrate (Atromid-S) on serum lipids in man

23 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Treatment of hyperlipidemias

23 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Type IV hyperlipoproteinemia. Clofibrate without dietary therapy

23 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Treatment of essential hyperlipidaemia

23 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Treatment of essential hypercholesterolemia with clofibrate and nicotinic acid

23 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.

23 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

23 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Combined hyperlipoproteinemia. Evidence for a new lipoprotein phenotype.

23 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

23 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

STUDIES OF THE COMPOSITION AND STRUCTURE OF SERUM LIPOPROTEINS: ISOLATION, PURIFICATION, AND CHARACTERIZATION OF VERY LOW DENSITY LIPOPROTEINS OF HUMAN SERUM

23 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia

23 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Response of hyperlipoproteinemia to colestipol

23 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Changes in high-density lipoprotein protein composition after heparin-induced lipolysis.

23 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Effect of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia during the first week of treatment

23 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Effect of ethyl p-chlorophenoxyisobutyrate on rat adipose lipoprotein lipase activity

23 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Effect of clofibrate on lipoprotein metabolism in hyperlipidemic rats

23 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia

23 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype.

23 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction.

23 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

23 December 2022

32

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Analysis of change in ultracentrifugal lipoprotein profiles following heparin and ethyl-p-chlorophenoxyiso-butyrate administration

23 December 2022

33

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

Treatment of Hypercholesterolemia by Interference With Bile Acid Metabolism

23 December 2022

35

1 reference

https://api.crossref.org/works/10.1016/0021-9150(76)90003-4

23 December 2022

Identifiers

1 reference

16 September 2017

1 reference